1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Direct-to-Consumer Laboratory Testing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Direct-to-Consumer Laboratory Testing Market, by Product
8.1.1 Medical Genetic Laboratory Testing
8.1.1.1. Market Revenue and Forecast
8.1.2. Routine Clinical Laboratory Testing
8.1.2.1. Market Revenue and Forecast
9.1. Direct-to-Consumer Laboratory Testing Market, by Test Type
9.1.1. Genetic Testing
9.1.1.1. Market Revenue and Forecast
9.1.2. COVID-19
9.1.2.1. Market Revenue and Forecast
9.1.3. Cancer
9.1.3.1. Market Revenue and Forecast
9.1.4. Diabetes Testing
9.1.4.1. Market Revenue and Forecast
9.1.5. Disease Risk Assessment Testing
9.1.5.1. Market Revenue and Forecast
9.1.6. Sexually Transmitted Disease Testing
9.1.6.1. Market Revenue and Forecast
9.1.7. Routine Testing
9.1.7.1. Market Revenue and Forecast
9.1.8. Complete Blood Count
9.1.8.1. Market Revenue and Forecast
9.1.9. Complete Blood Count
9.1.9.1. Market Revenue and Forecast
9.1.10. Thyroid Stimulating Hormone Testing
9.1.10.1. Market Revenue and Forecast
9.1.11. Other
9.1.11.1. Market Revenue and Forecast
10.1. Direct-to-Consumer Laboratory Testing Market, by Sample Type
10.1.1. Blood
10.1.1.1. Market Revenue and Forecast
10.1.2. Urine
10.1.2.1. Market Revenue and Forecast
10.1.3. Saliva
10.1.3.1. Market Revenue and Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product
11.1.2. Market Revenue and Forecast, by Test Type
11.1.3. Market Revenue and Forecast, by Sample Type
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product
11.1.4.2. Market Revenue and Forecast, by Test Type
11.1.4.3. Market Revenue and Forecast, by Sample Type
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product
11.1.5.2. Market Revenue and Forecast, by Test Type
11.1.5.3. Market Revenue and Forecast, by Sample Type
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product
11.2.2. Market Revenue and Forecast, by Test Type
11.2.3. Market Revenue and Forecast, by Sample Type
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product
11.2.4.2. Market Revenue and Forecast, by Test Type
11.2.4.3. Market Revenue and Forecast, by Sample Type
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product
11.2.5.2. Market Revenue and Forecast, by Test Type
11.2.5.3. Market Revenue and Forecast, by Sample Type
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product
11.2.6.2. Market Revenue and Forecast, by Test Type
11.2.6.3. Market Revenue and Forecast, by Sample Type
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product
11.2.7.2. Market Revenue and Forecast, by Test Type
11.2.7.3. Market Revenue and Forecast, by Sample Type
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product
11.3.2. Market Revenue and Forecast, by Test Type
11.3.3. Market Revenue and Forecast, by Sample Type
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product
11.3.4.2. Market Revenue and Forecast, by Test Type
11.3.4.3. Market Revenue and Forecast, by Sample Type
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product
11.3.5.2. Market Revenue and Forecast, by Test Type
11.3.5.3. Market Revenue and Forecast, by Sample Type
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product
11.3.6.2. Market Revenue and Forecast, by Test Type
11.3.6.3. Market Revenue and Forecast, by Sample Type
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product
11.3.7.2. Market Revenue and Forecast, by Test Type
11.3.7.3. Market Revenue and Forecast, by Sample Type
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product
11.4.2. Market Revenue and Forecast, by Test Type
11.4.3. Market Revenue and Forecast, by Sample Type
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product
11.4.4.2. Market Revenue and Forecast, by Test Type
11.4.4.3. Market Revenue and Forecast, by Sample Type
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product
11.4.5.2. Market Revenue and Forecast, by Test Type
11.4.5.3. Market Revenue and Forecast, by Sample Type
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product
11.4.6.2. Market Revenue and Forecast, by Test Type
11.4.6.3. Market Revenue and Forecast, by Sample Type
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product
11.4.7.2. Market Revenue and Forecast, by Test Type
11.4.7.3. Market Revenue and Forecast, by Sample Type
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product
11.5.2. Market Revenue and Forecast, by Test Type
11.5.3. Market Revenue and Forecast, by Sample Type
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product
11.5.4.2. Market Revenue and Forecast, by Test Type
11.5.4.3. Market Revenue and Forecast, by Sample Type
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product
11.5.5.2. Market Revenue and Forecast, by Test Type
11.5.5.3. Market Revenue and Forecast, by Sample Type
12.1. 23andMe, Inc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Ambry Genetics Corp.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Ancestry.com LLC
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Any Lab Test Now, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Color Genomics, Inc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Counsyl, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. DanteLabs Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Direct Laboratory Services, LLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Eastern Biotech & Life Sciences
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. EasyDNA
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
